US Jobs Report Faces Another Delay Amid Ongoing Government Shutdown Divis Laboratories Q4 Results Net Profit Rises 13 to Rs 751 Crore Revenue Up 10 Company Declares Rs 30 Dividend Pokmon Card Market Surges as Nostalgia Speculation and Celebrity Interest Drive MultiMillion Dollar Sales US Consumer Prices Rise 38 in April Exceeding Expectations Mortgage Rates Show Mixed Movement as 30Year Fixed Declines Adjustable Rates Slide New Ferry Service Links Taiwan and Japans Ishigaki Island Boosting Regional Tourism and Trade ORN Q1 2026 Earnings EPS Surprises Positively Revenue Uncertainty Weighs on Shares Acrivon Therapeutics Q1 2026 Earnings Narrower Loss Per Share as Pipeline Progress Continues ARKO Petroleum Corp Q1 2026 Earnings EPS Surpasses Estimates as Fuel Margins Hold Steady MOS Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Rises on Other Factors AAT Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Weakness Lite Strategy Inc LITS Q4 2024 Earnings Significant EPS Miss Signals Operational Challenges Array Technologies ARRY Reclaims Ground Approaching Key Resistance After 154 Gain Upstream Bio UPB Edges Higher Amid Quiet Trading Holds Above Key Support Addex Therapeutics ADXN Holds Gains Amid Biotech Sector Momentum Traeger Inc COOK Faces Selling Pressure Testing Key Support Levels Quantum Biopharma Ltd QNTM Surges 18 Key Levels and Potential Drivers Meta Settles Social Media Addiction Lawsuit With US School District Averting Landmark Trial Verisk Analytics Q1 2026 Earnings EPS Beat Fuels Solid Start to Fiscal Year Aimei Health Technology Rights AFJKR Consolidates at 029 Amid Low Volatility EQT Q1 2026 Earnings Strong EPS Beat as Natural Gas Fundamentals Tighten NCPL Q1 2026 Earnings Significant EPS Miss Amid Sharp Stock Rally The Battle for AI Talent MillionDollar Salaries and BillionDollar Stakes in the Race to AGI TRMB Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency FVCB Q1 2026 Earnings EPS Beats Estimates by 398 Stock Gains 064 Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues Northrop Grumman NOC Q1 2026 Earnings Defense Contractor Beats EPS Estimates Amid Steady Demand